HHS reports increase in buprenorphine providers, naloxone prescriptions
The number of health care providers with waivers to prescribe buprenorphine for opioid use disorder increased 19% between October 2021 and September 2022 to 132,005, the Department of Health and Human Services announced today. HHS last April issued revised practice guidelines for administering buprenorphine to treat OUD, which eased requirements for clinicians to obtain a waiver to treat OUD patients with buprenorphine. According to HHS, pharmacy-filled prescriptions for the overdose reversal drug naloxone also increased 37% over the period, from a three-month average of 109,414 prescriptions in October 2021 to 150,213 in August 2022.
Related News Articles
Headline
Americans across 43 states enrolled in health plans from the nation’s four largest commercial health insurers face potential disparities in finding in-network…
Perspective
Few patient populations are more vulnerable to the shifting winds around health care today than Medicare beneficiaries who need specialized, high-acuity and…
Headline
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…
Headline
The Centers for Medicare and Medicaid Services April 8 issued guidance on implementing a provision within the reconciliation bill passed in July 2025 regarding…
Headline
The Centers for Medicare & Medicaid Services April 2 announced the release of new data on health care utilization and prices at the provider and service…
Headline
In a commentary published March 26 by Healthcare Dive, AHA President and CEO Rick Pollack details why a new facility administrative policy from Anthem will…